287 related articles for article (PubMed ID: 16131808)
1. Effects of new peritoneal dialysis solutions on leukocyte recruitment in the rat peritoneal membrane.
Mortier S; Faict D; Gericke M; Lameire N; De Vriese A
Nephron Exp Nephrol; 2005; 101(4):e139-45. PubMed ID: 16131808
[TBL] [Abstract][Full Text] [Related]
2. Effects of conventional and new peritoneal dialysis fluids on leukocyte recruitment in the rat peritoneal membrane.
Mortier S; De Vriese AS; McLoughlin RM; Topley N; Schaub TP; Passlick-Deetjen J; Lameire NH
J Am Soc Nephrol; 2003 May; 14(5):1296-306. PubMed ID: 12707398
[TBL] [Abstract][Full Text] [Related]
3. Long-term exposure to new peritoneal dialysis solutions: Effects on the peritoneal membrane.
Mortier S; Faict D; Schalkwijk CG; Lameire NH; De Vriese AS
Kidney Int; 2004 Sep; 66(3):1257-65. PubMed ID: 15327425
[TBL] [Abstract][Full Text] [Related]
4. Improved biocompatibility of bicarbonate/lactate-buffered PDF is not related to pH.
Zareie M; Keuning ED; ter Wee PM; Schalkwijk CG; Beelen RH; van den Born J
Nephrol Dial Transplant; 2006 Jan; 21(1):208-16. PubMed ID: 16263741
[TBL] [Abstract][Full Text] [Related]
5. Biocompatibility and buffers: effect of bicarbonate-buffered peritoneal dialysis fluids on peritoneal cell function.
Jörres A; Bender TO; Finn A; Witowski J; Fröhlich S; Gahl GM; Frei U; Keck H; Passlick-Deetjen J
Kidney Int; 1998 Dec; 54(6):2184-93. PubMed ID: 9853285
[TBL] [Abstract][Full Text] [Related]
6. Benefits of switching from a conventional to a low-GDP bicarbonate/lactate-buffered dialysis solution in a rat model.
Mortier S; Faict D; Lameire NH; De Vriese AS
Kidney Int; 2005 Apr; 67(4):1559-65. PubMed ID: 15780112
[TBL] [Abstract][Full Text] [Related]
7. Better preservation of the peritoneum in rats exposed to amino acid-based peritoneal dialysis fluid.
Zareie M; van Lambalgen AA; ter Wee PM; Hekking LH; Keuning ED; Schadee-Eestermans IL; Faict D; Degréve B; Tangelder GJ; Beelen RH; van den Born J
Perit Dial Int; 2005; 25(1):58-67. PubMed ID: 15770927
[TBL] [Abstract][Full Text] [Related]
8. Peritoneal dialysis fluid bioincompatibility and new vessel formation promote leukocyte-endothelium interactions in a chronic rat model for peritoneal dialysis.
Schilte MN; Fabbrini P; Wee PM; Keuning ED; Zareie M; Tangelder GJ; Van Lambalgen AA; Beelen RH; Van Den Born J
Microcirculation; 2010 May; 17(4):271-80. PubMed ID: 20536740
[TBL] [Abstract][Full Text] [Related]
9. Effects of a new bicarbonate/lactate-buffered neutral peritoneal dialysis fluid for peritoneal failure in patients undergoing peritoneal dialysis.
Hoshino T; Ishii H; Kitano T; Shindo M; Miyazawa H; Yamada H; Ito K; Ueda Y; Kaku Y; Hirai K; Mori H; Ookawara S; Tabei K; Morishita Y
Discov Med; 2016 Feb; 21(114):81-8. PubMed ID: 27011043
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic effects of peritoneal dialysis solutions on the rat peritoneal membrane: role of acidity, buffer choice, glucose concentration, and glucose degradation products.
Mortier S; De Vriese AS; Van de Voorde J; Schaub TP; Passlick-Deetjen J; Lameire NH
J Am Soc Nephrol; 2002 Feb; 13(2):480-489. PubMed ID: 11805178
[TBL] [Abstract][Full Text] [Related]
11. Osmotic agents and buffers in peritoneal dialysis solution: monocyte cytokine release and in vitro cytotoxicity.
Plum J; Schoenicke G; Grabensee B
Am J Kidney Dis; 1997 Sep; 30(3):413-22. PubMed ID: 9292571
[TBL] [Abstract][Full Text] [Related]
12. The effects of peritoneal dialysis solutions on peritoneal host defense.
Mortier S; Lameire NH; De Vriese AS
Perit Dial Int; 2004; 24(2):123-38. PubMed ID: 15119633
[TBL] [Abstract][Full Text] [Related]
13. The in vitro biocompatibility performance of a 25 mmol/L bicarbonate/10 mmol/L lactate-buffered peritoneal dialysis fluid.
Skoufos L; Topley N; Cooker L; Dawnay A; Millar DJ; Holmes CJ; Faict D
Kidney Int Suppl; 2003 Dec; (88):S94-9. PubMed ID: 14870882
[TBL] [Abstract][Full Text] [Related]
14. Bicarbonate/lactate dialysis solution improves in vivo function of peritoneal host defense in rats.
Pawlaczyk K; Kuzlan-Pawlaczyk M; Wieczorowska-Tobis K; Polubinska A; Wisniewska J; Faict D; Holmes CJ; Breborowicz A
Perit Dial Int; 1999; 19 Suppl 2():S370-7. PubMed ID: 10406549
[TBL] [Abstract][Full Text] [Related]
15. Acute effects of peritoneal dialysis solutions in the mesenteric microcirculation.
Frajewicki V; Brod V; Kushnir D; Kohan R; Bitterman H
Transl Res; 2009 May; 153(5):249-56. PubMed ID: 19375686
[TBL] [Abstract][Full Text] [Related]
16. The application of animal models to study the biocompatibility of bicarbonate-buffered peritoneal dialysis solutions.
ter Wee PM; Beelen RH; van den Born J
Kidney Int Suppl; 2003 Dec; (88):S75-83. PubMed ID: 14870880
[TBL] [Abstract][Full Text] [Related]
17. Beneficial effects of aminoguanidine on peritoneal microcirculation and tissue remodelling in a rat model of PD.
Zareie M; Tangelder GJ; ter Wee PM; Hekking LH; van Lambalgen AA; Keuning ED; Schadee-Eestermans IL; Schalkwijk CG; Beelen RH; van den Born J
Nephrol Dial Transplant; 2005 Dec; 20(12):2783-92. PubMed ID: 16204296
[TBL] [Abstract][Full Text] [Related]
18. Bicarbonate/lactate- and bicarbonate-buffered peritoneal dialysis fluids improve ex vivo peritoneal macrophage TNFalpha secretion.
MacKenzie RK; Holmes CJ; Moseley A; Jenkins JP; Williams JD; Coles GA; Faict D; Topley N
J Am Soc Nephrol; 1998 Aug; 9(8):1499-506. PubMed ID: 9697673
[TBL] [Abstract][Full Text] [Related]
19. Biocompatibility of a 1.1% amino acid-containing peritoneal dialysis fluid compared to a 2.27% glucose-based peritoneal dialysis fluid.
Brulez HF; Dekker HA; Oe PL; Verbeelen D; ter Wee PM; Verbrugh HA
Nephron; 1996; 74(1):26-32. PubMed ID: 8883016
[TBL] [Abstract][Full Text] [Related]
20. Longer-Period Effects of Bicarbonate/Lactate-Buffered Neutral Peritoneal Dialysis Fluid in Patients Undergoing Peritoneal Dialysis.
Hoshino T; Kaneko S; Minato S; Yanai K; Mutsuyoshi Y; Ishii H; Kitano T; Shindo M; Miyazawa H; Aomatsu A; Ito K; Ueda Y; Hirai K; Ookawara S; Morishita Y
Ther Apher Dial; 2018 Dec; 22(6):641-648. PubMed ID: 30014626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
